Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 16, 2023

BUY
$0.32 - $1.88 $4,288 - $25,192
13,400 New
13,400 $4,000
Q2 2022

Aug 15, 2022

SELL
$1.12 - $2.18 $11,872 - $23,108
-10,600 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.63 - $3.63 $109,047 - $242,847
-66,900 Reduced 86.32%
10,600 $28,000
Q3 2021

Nov 15, 2021

BUY
$2.71 - $5.9 $210,025 - $457,250
77,500 New
77,500 $313,000

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $60.3M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.